Michael CRT - Viemed Healthcare President
| VMD Stock | USD 8.56 0.10 1.15% |
Insider
Michael CRT is President of Viemed Healthcare
| Age | 47 |
| Address | 625 East Kaliste Saloom Road, Lafayette, LA, United States, 70508 |
| Phone | 337 504 3802 |
| Web | https://www.viemed.com |
Viemed Healthcare Management Efficiency
The company has Return on Asset of 0.0686 % which means that on every $100 spent on assets, it made $0.0686 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0888 %, implying that it generated $0.0888 on every 100 dollars invested. Viemed Healthcare's management efficiency ratios could be used to measure how well Viemed Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2024, Return On Tangible Assets is expected to decline to 0.08. In addition to that, Return On Capital Employed is expected to decline to 0.11. At present, Viemed Healthcare's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 684.7 K, whereas Non Currrent Assets Other are forecasted to decline to about 842.6 K.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Quick | Orthofix Medical | N/A | |
| Geoffrey Rose | Pulmonx Corp | 50 | |
| Mark CPA | Treace Medical Concepts | 54 | |
| John Ordway | Sight Sciences | N/A | |
| John Treace | Treace Medical Concepts | 52 | |
| Jesse Selnick | Sight Sciences | N/A | |
| Mark Saxton | Neuropace | 59 | |
| Joseph Powers | Si Bone | 64 | |
| Andre Marquette | Neuropace | N/A | |
| Steve Deitsch | Paragon 28 | N/A | |
| Stacie Rodgers | Sight Sciences | N/A | |
| Alaleh Nouri | Procept Biorobotics Corp | 45 | |
| Laura MBA | Si Bone | 57 | |
| Andrew Quick | Avita Medical | 53 | |
| Patrick Mercer | IRIDEX | 52 | |
| BA Chemistry | Orthofix Medical | 63 | |
| Levant Tinaz | Profound Medical Corp | N/A | |
| Lisa Paul | Pulmonx Corp | 60 | |
| Michael Favet | Neuropace | 54 | |
| Chad Holman | Varex Imaging Corp | N/A | |
| Ehab Esmail | Orthofix Medical | 52 | |
Management Performance
| Return On Equity | 0.0888 | ||||
| Return On Asset | 0.0686 |
Viemed Healthcare Leadership Team
Elected by the shareholders, the Viemed Healthcare's board of directors comprises two types of representatives: Viemed Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viemed. The board's role is to monitor Viemed Healthcare's management team and ensure that shareholders' interests are well served. Viemed Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viemed Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Zehnder, COO Director | ||
| Robert LLB, Co Sec | ||
| Jeremy Trahan, Chief Transactions | ||
| Patrick Eagan, General Secretary | ||
| William MD, Chief Director | ||
| Casey Hoyt, CEO Director | ||
| Michael Freeman, Chief Officer | ||
| Michael CRT, President | ||
| Jerome II, Vice Sales | ||
| Trae Fitzgerald, Chief Officer |
Viemed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Viemed Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0888 | ||||
| Return On Asset | 0.0686 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 333.1 M | ||||
| Shares Outstanding | 38.94 M | ||||
| Shares Owned By Insiders | 12.63 % | ||||
| Shares Owned By Institutions | 66.68 % | ||||
| Number Of Shares Shorted | 361.18 K | ||||
| Price To Earning | 29.88 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Viemed Healthcare is a strong investment it is important to analyze Viemed Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Viemed Healthcare's future performance. For an informed investment choice regarding Viemed Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viemed Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Viemed Stock refer to our How to Trade Viemed Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viemed Healthcare. If investors know Viemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viemed Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.425 | Earnings Share 0.25 | Revenue Per Share 5.534 | Quarterly Revenue Growth 0.174 | Return On Assets 0.0686 |
The market value of Viemed Healthcare is measured differently than its book value, which is the value of Viemed that is recorded on the company's balance sheet. Investors also form their own opinion of Viemed Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Viemed Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viemed Healthcare's market value can be influenced by many factors that don't directly affect Viemed Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viemed Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viemed Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viemed Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.